Page last updated: 2024-12-05

gallium arsenide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Gallium arsenide (GaAs) is a compound semiconductor composed of equal parts gallium and arsenic. It is typically produced by reacting gallium and arsenic at high temperatures, often through a process called vapor phase epitaxy. GaAs is a direct bandgap semiconductor, which makes it highly efficient for emitting and absorbing light, leading to its use in various optoelectronic devices, including lasers, LEDs, and solar cells. It has a higher electron mobility than silicon, making it suitable for high-speed transistors and integrated circuits. GaAs is also known for its resistance to radiation damage, making it valuable in space applications and high-power electronics. Its unique properties and applications have led to extensive research in areas such as high-frequency electronics, optical communication, and renewable energy.'

Cross-References

ID SourceID
PubMed CID14770
MeSH IDM0126878

Synonyms (24)

Synonym
ec 215-114-8
unii-27fc46ga44
27fc46ga44 ,
einecs 215-114-8
gallium arsenide (gaas)
hsdb 4376
ccris 4020
gallium monoarsenide (gaas)
gallium monoarsenide
gallium arsenide, (single crystal substrate), <100>, diam. x thickness 2 in. x 0.5 mm
gallium arsenide, pieces, 99.999% trace metals basis
NCGC00164143-01
gallium arsenide
1303-00-0
gaas
gallanylidynearsane
FT-0695014
gallium arsenide [mi]
DTXSID2023779 ,
mfcd00011017
Q422819
arsinogallane
gallium arsenatum
dtxcid403779

Research Excerpts

Overview

Gallium arsenide (GaAs) is an intermetallic compound used in the electronics industry as a semiconductor. It has proved to be an ideal substrate material for some uses but is associated with unique health hazards.

ExcerptReferenceRelevance
"Gallium arsenide (GaAs) is a promising candidate as a platform for optical biosensing devices due to its enabling optoelectronic properties. "( Biofunctionalisation of gallium arsenide with neutravidin.
Borri, P; Langbein, W; Masia, F; Morgan, DJ; Santos Gomes, B, 2022
)
2.47
"Gallium arsenide (GaAs) is a versatile alternative material vs."( Gallium arsenide waveguides as a platform for direct mid-infrared vibrational spectroscopy.
Haas, J; Kolm, C; Krska, R; Mizaikoff, B; Stach, R, 2020
)
2.72
"Gallium arsenide (GaAs) is a material widely used in electronic devices. "( Gallium arsenide (GaAs) leaching behavior and surface chemistry changes in response to pH and O
Field, JA; Ramos-Ruiz, A; Sierra-Alvarez, R; Sun, W, 2018
)
3.37
"Gallium arsenide (GaAs) is an important semiconductor material. "( Evaluation of the carcinogenicity of gallium arsenide.
Bomhard, EM; Cohen, SM; Gelbke, HP; Schenk, H; Williams, GM, 2013
)
2.11
"Gallium arsenide is an important semiconductor material marketed in the shape of wafers and thus is not hazardous to the end user. "( Evaluation of the male reproductive toxicity of gallium arsenide.
Bomhard, EM; Cohen, SM; Gelbke, HP; Williams, GM, 2012
)
2.08
"Gallium arsenide (GaAs) is an intermetallic compound used in the electronics industry as a semiconductor. "( Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
Lewis, TA; McCoy, KL; Munson, AE, 1996
)
3.18
"Gallium arsenide (GaAs) is an intermetallic semiconductor compound used in the electronics industry. "( Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.
Caffrey-Nolan, RE; McCoy, KL, 1998
)
2.07
"Gallium arsenide (GaAs) is a semiconductor utilized in the electronics industry. "( Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages.
Hartmann, CB; Lewis, TA; McCoy, KL, 1998
)
3.19
"Gallium arsenide has proved to be an ideal substrate material for some uses but is associated with unique health hazards."( Gallium arsenide.
Harrison, RJ,
)
2.3
"Gallium arsenide (GaAs) is an intermetallic compound that is recognized as a potential toxicological risk to workers occupationally exposed to its dust. "( Pulmonary clearance and toxicity of respirable gallium arsenide particulates intratracheally instilled into rats.
Carter, DE; Webb, DR; Wilson, SE, 1987
)
1.97

Effects

Gallium arsenide (GaAs) has been shown previously to suppress the in vivo antibody-forming cell (AFC) response to sheep erythrocytes (SRBC) When administered intratracheally at concentrations between 50 and 200 mg/kg.

ExcerptReferenceRelevance
"Gallium arsenide (GaAs) has been shown previously to suppress the in vivo antibody-forming cell (AFC) response to sheep erythrocytes (SRBC) when administered intratracheally at concentrations between 50 and 200 mg/kg. "( Evidence for arsenic as the immunosuppressive component of gallium arsenide.
Burns, LA; Munson, AE; Saady, JJ; Sikorski, EE, 1991
)
1.97
"Gallium arsenide has proved to be an ideal substrate material for some uses but is associated with unique health hazards."( Gallium arsenide.
Harrison, RJ,
)
2.3

Actions

ExcerptReferenceRelevance
"The gallium arsenide had a lower solubility than any other arsenic compound and it had a disproportionate intensity of lung damage to suggest that the GaAs had a site of contact interaction and that oxidation reactions were important in its toxicity."( The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review.
Aposhian, HV; Carter, DE; Gandolfi, AJ, 2003
)
1.06

Toxicity

ExcerptReferenceRelevance
" From the present study, the toxic potency of these particles was provisionally estimated to be in the following order: InAs > GaAs > As2O3, at the dosage level used in this study."( Comparative study of the toxic effects of gallium arsenide, indium arsenide and arsenic trioxide following intratracheal instillations to the lung of Syrian golden hamsters.
Gotoh, K; Hirata, M; Inoue, N; Makita, Y; Omura, M; Tanaka, A; Yamazaki, K; Zhao, M, 2000
)
0.57
"Gallium arsenide (GaAs), a chemical compound of gallium and arsenic, causes various toxic effects including pulmonary diseases in animals."( In vitro toxicity of gallium arsenide in alveolar macrophages evaluated by magnetometry, cytochemistry and morphology.
Aizawa, Y; Karube, H; Kotani, M; Niitsuya, M; Okada, M; Okayasu, I, 1999
)
2.07
" Although the increased use of these materials has raised concerns about occupational exposure to them, there is little information regarding the adverse health effects to workers arising from exposure to these particles."( Toxicity of indium arsenide, gallium arsenide, and aluminium gallium arsenide.
Tanaka, A, 2004
)
0.61

Bioavailability

ExcerptReferenceRelevance
" The time- and concentration-dependent progressive nature of the lung and blood effects together with bioavailability data on gallium and arsenic lead us to conclude that the testicular/sperm effects are secondary to hypoxemia resulting from lung damage rather than due to a direct chemical effect of gallium or arsenide."( Evaluation of the male reproductive toxicity of gallium arsenide.
Bomhard, EM; Cohen, SM; Gelbke, HP; Williams, GM, 2012
)
0.63
" The available data on mode of action (MOA), genotoxicity and bioavailability do not support the contribution of As or Ga ions to the lung tumors in female rats."( Evaluation of the carcinogenicity of gallium arsenide.
Bomhard, EM; Cohen, SM; Gelbke, HP; Schenk, H; Williams, GM, 2013
)
0.66

Dosage Studied

ExcerptRelevanceReference
" Magnetometric evaluation of the effects of GaAs in rabbits dosed with 30 mg or 300 mg/animal showed significant decreased relaxation of iron particles at 1, 3, 7, 14, 21 and 28 days following instillation compared with the controls."( Magnetometric evaluation of the effects of gallium arsenide on the clearance and relaxation of iron particles.
Aizawa, Y; Chiyotani, K; Inokuchi, N; Karube, H; Kotani, M; Takata, T; Tatsumi, H, 1993
)
0.55
" From the present study, the toxic potency of these particles was provisionally estimated to be in the following order: InAs > GaAs > As2O3, at the dosage level used in this study."( Comparative study of the toxic effects of gallium arsenide, indium arsenide and arsenic trioxide following intratracheal instillations to the lung of Syrian golden hamsters.
Gotoh, K; Hirata, M; Inoue, N; Makita, Y; Omura, M; Tanaka, A; Yamazaki, K; Zhao, M, 2000
)
0.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
farnesoid X nuclear receptorHomo sapiens (human)Potency0.00080.375827.485161.6524AID588527
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00110.023723.228263.5986AID588543
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (440)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (2.73)18.7374
1990's41 (9.32)18.2507
2000's151 (34.32)29.6817
2010's207 (47.05)24.3611
2020's29 (6.59)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.55 (24.57)
Research Supply Index6.14 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index108.88 (26.88)
Search Engine Supply Index2.08 (0.95)

This Compound (62.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (1.77%)5.53%
Reviews7 (1.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other438 (96.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]